Global Guselkumab Injection Market Growth 2022-2028
- LP 4952453
- 79 Pages
- May 2022
- Pharmaceuticals
The United States Guselkumab Injection market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Guselkumab Injection market, reaching US$ million by the year 2028. As for the Europe Guselkumab Injection landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Guselkumab Injection players cover Janssen Biotech, , , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Guselkumab Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
100mg Type
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Plaque Psoriasis
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Janssen Biotech
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Guselkumab Injection Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Guselkumab Injection by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Guselkumab Injection by Country/Region, 2017, 2022 & 2028
2.2 Guselkumab Injection Segment by Type
2.2.1 100mg Type
2.2.2 Other
2.3 Guselkumab Injection Sales by Type
2.3.1 Global Guselkumab Injection Sales Market Share by Type (2017-2022)
2.3.2 Global Guselkumab Injection Revenue and Market Share by Type (2017-2022)
2.3.3 Global Guselkumab Injection Sale Price by Type (2017-2022)
2.4 Guselkumab Injection Segment by Application
2.4.1 Plaque Psoriasis
2.4.2 Other
2.5 Guselkumab Injection Sales by Application
2.5.1 Global Guselkumab Injection Sale Market Share by Application (2017-2022)
2.5.2 Global Guselkumab Injection Revenue and Market Share by Application (2017-2022)
2.5.3 Global Guselkumab Injection Sale Price by Application (2017-2022)
3 Global Guselkumab Injection by Company
3.1 Global Guselkumab Injection Breakdown Data by Company
3.1.1 Global Guselkumab Injection Annual Sales by Company (2020-2022)
3.1.2 Global Guselkumab Injection Sales Market Share by Company (2020-2022)
3.2 Global Guselkumab Injection Annual Revenue by Company (2020-2022)
3.2.1 Global Guselkumab Injection Revenue by Company (2020-2022)
3.2.2 Global Guselkumab Injection Revenue Market Share by Company (2020-2022)
3.3 Global Guselkumab Injection Sale Price by Company
3.4 Key Manufacturers Guselkumab Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Guselkumab Injection Product Location Distribution
3.4.2 Players Guselkumab Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Guselkumab Injection by Geographic Region
4.1 World Historic Guselkumab Injection Market Size by Geographic Region (2017-2022)
4.1.1 Global Guselkumab Injection Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Guselkumab Injection Annual Revenue by Geographic Region
4.2 World Historic Guselkumab Injection Market Size by Country/Region (2017-2022)
4.2.1 Global Guselkumab Injection Annual Sales by Country/Region (2017-2022)
4.2.2 Global Guselkumab Injection Annual Revenue by Country/Region
4.3 Americas Guselkumab Injection Sales Growth
4.4 APAC Guselkumab Injection Sales Growth
4.5 Europe Guselkumab Injection Sales Growth
4.6 Middle East & Africa Guselkumab Injection Sales Growth
5 Americas
5.1 Americas Guselkumab Injection Sales by Country
5.1.1 Americas Guselkumab Injection Sales by Country (2017-2022)
5.1.2 Americas Guselkumab Injection Revenue by Country (2017-2022)
5.2 Americas Guselkumab Injection Sales by Type
5.3 Americas Guselkumab Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Guselkumab Injection Sales by Region
6.1.1 APAC Guselkumab Injection Sales by Region (2017-2022)
6.1.2 APAC Guselkumab Injection Revenue by Region (2017-2022)
6.2 APAC Guselkumab Injection Sales by Type
6.3 APAC Guselkumab Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Guselkumab Injection by Country
7.1.1 Europe Guselkumab Injection Sales by Country (2017-2022)
7.1.2 Europe Guselkumab Injection Revenue by Country (2017-2022)
7.2 Europe Guselkumab Injection Sales by Type
7.3 Europe Guselkumab Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Guselkumab Injection by Country
8.1.1 Middle East & Africa Guselkumab Injection Sales by Country (2017-2022)
8.1.2 Middle East & Africa Guselkumab Injection Revenue by Country (2017-2022)
8.2 Middle East & Africa Guselkumab Injection Sales by Type
8.3 Middle East & Africa Guselkumab Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Guselkumab Injection
10.3 Manufacturing Process Analysis of Guselkumab Injection
10.4 Industry Chain Structure of Guselkumab Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Guselkumab Injection Distributors
11.3 Guselkumab Injection Customer
12 World Forecast Review for Guselkumab Injection by Geographic Region
12.1 Global Guselkumab Injection Market Size Forecast by Region
12.1.1 Global Guselkumab Injection Forecast by Region (2023-2028)
12.1.2 Global Guselkumab Injection Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Guselkumab Injection Forecast by Type
12.7 Global Guselkumab Injection Forecast by Application
13 Key Players Analysis
13.1 Janssen Biotech
13.1.1 Janssen Biotech Company Information
13.1.2 Janssen Biotech Guselkumab Injection Product Offered
13.1.3 Janssen Biotech Guselkumab Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Janssen Biotech Main Business Overview
13.1.5 Janssen Biotech Latest Developments
14 Research Findings and Conclusion
Table 1. Guselkumab Injection Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Guselkumab Injection Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 100mg Type
Table 4. Major Players of Other
Table 5. Global Guselkumab Injection Sales by Type (2017-2022) & (K Units)
Table 6. Global Guselkumab Injection Sales Market Share by Type (2017-2022)
Table 7. Global Guselkumab Injection Revenue by Type (2017-2022) & ($ million)
Table 8. Global Guselkumab Injection Revenue Market Share by Type (2017-2022)
Table 9. Global Guselkumab Injection Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Guselkumab Injection Sales by Application (2017-2022) & (K Units)
Table 11. Global Guselkumab Injection Sales Market Share by Application (2017-2022)
Table 12. Global Guselkumab Injection Revenue by Application (2017-2022)
Table 13. Global Guselkumab Injection Revenue Market Share by Application (2017-2022)
Table 14. Global Guselkumab Injection Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Guselkumab Injection Sales by Company (2020-2022) & (K Units)
Table 16. Global Guselkumab Injection Sales Market Share by Company (2020-2022)
Table 17. Global Guselkumab Injection Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Guselkumab Injection Revenue Market Share by Company (2020-2022)
Table 19. Global Guselkumab Injection Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Guselkumab Injection Producing Area Distribution and Sales Area
Table 21. Players Guselkumab Injection Products Offered
Table 22. Guselkumab Injection Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Guselkumab Injection Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Guselkumab Injection Sales Market Share Geographic Region (2017-2022)
Table 27. Global Guselkumab Injection Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Guselkumab Injection Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Guselkumab Injection Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Guselkumab Injection Sales Market Share by Country/Region (2017-2022)
Table 31. Global Guselkumab Injection Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Guselkumab Injection Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Guselkumab Injection Sales by Country (2017-2022) & (K Units)
Table 34. Americas Guselkumab Injection Sales Market Share by Country (2017-2022)
Table 35. Americas Guselkumab Injection Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Guselkumab Injection Revenue Market Share by Country (2017-2022)
Table 37. Americas Guselkumab Injection Sales by Type (2017-2022) & (K Units)
Table 38. Americas Guselkumab Injection Sales Market Share by Type (2017-2022)
Table 39. Americas Guselkumab Injection Sales by Application (2017-2022) & (K Units)
Table 40. Americas Guselkumab Injection Sales Market Share by Application (2017-2022)
Table 41. APAC Guselkumab Injection Sales by Region (2017-2022) & (K Units)
Table 42. APAC Guselkumab Injection Sales Market Share by Region (2017-2022)
Table 43. APAC Guselkumab Injection Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Guselkumab Injection Revenue Market Share by Region (2017-2022)
Table 45. APAC Guselkumab Injection Sales by Type (2017-2022) & (K Units)
Table 46. APAC Guselkumab Injection Sales Market Share by Type (2017-2022)
Table 47. APAC Guselkumab Injection Sales by Application (2017-2022) & (K Units)
Table 48. APAC Guselkumab Injection Sales Market Share by Application (2017-2022)
Table 49. Europe Guselkumab Injection Sales by Country (2017-2022) & (K Units)
Table 50. Europe Guselkumab Injection Sales Market Share by Country (2017-2022)
Table 51. Europe Guselkumab Injection Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Guselkumab Injection Revenue Market Share by Country (2017-2022)
Table 53. Europe Guselkumab Injection Sales by Type (2017-2022) & (K Units)
Table 54. Europe Guselkumab Injection Sales Market Share by Type (2017-2022)
Table 55. Europe Guselkumab Injection Sales by Application (2017-2022) & (K Units)
Table 56. Europe Guselkumab Injection Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Guselkumab Injection Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Guselkumab Injection Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Guselkumab Injection Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Guselkumab Injection Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Guselkumab Injection Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Guselkumab Injection Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Guselkumab Injection Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Guselkumab Injection Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Guselkumab Injection
Table 66. Key Market Challenges & Risks of Guselkumab Injection
Table 67. Key Industry Trends of Guselkumab Injection
Table 68. Guselkumab Injection Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Guselkumab Injection Distributors List
Table 71. Guselkumab Injection Customer List
Table 72. Global Guselkumab Injection Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Guselkumab Injection Sales Market Forecast by Region
Table 74. Global Guselkumab Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Guselkumab Injection Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Guselkumab Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Guselkumab Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Guselkumab Injection Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Guselkumab Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Guselkumab Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Guselkumab Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Guselkumab Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Guselkumab Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Guselkumab Injection Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Guselkumab Injection Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Guselkumab Injection Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Guselkumab Injection Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Guselkumab Injection Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Guselkumab Injection Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Guselkumab Injection Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Guselkumab Injection Revenue Market Share Forecast by Application (2023-2028)
Table 92. Janssen Biotech Basic Information, Guselkumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Janssen Biotech Guselkumab Injection Product Offered
Table 94. Janssen Biotech Guselkumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Janssen Biotech Main Business
Table 96. Janssen Biotech Latest Developments
List of Figures
Figure 1. Picture of Guselkumab Injection
Figure 2. Guselkumab Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Guselkumab Injection Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Guselkumab Injection Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Guselkumab Injection Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 100mg Type
Figure 10. Product Picture of Other
Figure 11. Global Guselkumab Injection Sales Market Share by Type in 2021
Figure 12. Global Guselkumab Injection Revenue Market Share by Type (2017-2022)
Figure 13. Guselkumab Injection Consumed in Plaque Psoriasis
Figure 14. Global Guselkumab Injection Market: Plaque Psoriasis (2017-2022) & (K Units)
Figure 15. Guselkumab Injection Consumed in Other
Figure 16. Global Guselkumab Injection Market: Other (2017-2022) & (K Units)
Figure 17. Global Guselkumab Injection Sales Market Share by Application (2017-2022)
Figure 18. Global Guselkumab Injection Revenue Market Share by Application in 2021
Figure 19. Guselkumab Injection Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Guselkumab Injection Revenue Market Share by Company in 2021
Figure 21. Global Guselkumab Injection Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Guselkumab Injection Revenue Market Share by Geographic Region in 2021
Figure 23. Global Guselkumab Injection Sales Market Share by Region (2017-2022)
Figure 24. Global Guselkumab Injection Revenue Market Share by Country/Region in 2021
Figure 25. Americas Guselkumab Injection Sales 2017-2022 (K Units)
Figure 26. Americas Guselkumab Injection Revenue 2017-2022 ($ Millions)
Figure 27. APAC Guselkumab Injection Sales 2017-2022 (K Units)
Figure 28. APAC Guselkumab Injection Revenue 2017-2022 ($ Millions)
Figure 29. Europe Guselkumab Injection Sales 2017-2022 (K Units)
Figure 30. Europe Guselkumab Injection Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Guselkumab Injection Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Guselkumab Injection Revenue 2017-2022 ($ Millions)
Figure 33. Americas Guselkumab Injection Sales Market Share by Country in 2021
Figure 34. Americas Guselkumab Injection Revenue Market Share by Country in 2021
Figure 35. United States Guselkumab Injection Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Guselkumab Injection Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Guselkumab Injection Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Guselkumab Injection Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Guselkumab Injection Sales Market Share by Region in 2021
Figure 40. APAC Guselkumab Injection Revenue Market Share by Regions in 2021
Figure 41. China Guselkumab Injection Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Guselkumab Injection Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Guselkumab Injection Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Guselkumab Injection Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Guselkumab Injection Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Guselkumab Injection Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Guselkumab Injection Sales Market Share by Country in 2021
Figure 48. Europe Guselkumab Injection Revenue Market Share by Country in 2021
Figure 49. Germany Guselkumab Injection Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Guselkumab Injection Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Guselkumab Injection Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Guselkumab Injection Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Guselkumab Injection Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Guselkumab Injection Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Guselkumab Injection Revenue Market Share by Country in 2021
Figure 56. Egypt Guselkumab Injection Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Guselkumab Injection Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Guselkumab Injection Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Guselkumab Injection Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Guselkumab Injection Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Guselkumab Injection in 2021
Figure 62. Manufacturing Process Analysis of Guselkumab Injection
Figure 63. Industry Chain Structure of Guselkumab Injection
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
